To investigate the role of T1IFN signaling in ILC2s, we assessed mice treated with anti-T1IFN receptor and observed reduced amphiregulin (AREG) production in ILC2s and exaggeration of colitis in wild-type (WT) and Rag2-deficient mice, which was rescued by supplementation with AREG. This evidence concerns the gene AREG and colitis.